MB

MPM BioImpact Portfolio holdings

AUM $1.29B
1-Year Est. Return 141.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+141.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$611M
AUM Growth
+$33.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$18M
2
+$7.41M
3
+$6.74M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$6.34M
5
LQDA icon
Liquidia Corp
LQDA
+$4.34M

Top Sells

1
+$23M
2
+$14.8M
3
+$14.8M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$12.3M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$10.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$46.1M 7.54%
100,415
2
$45.4M 7.42%
7,648,268
3
$33.1M 5.42%
760,022
4
$31.2M 5.1%
3,406,955
5
$27.9M 4.57%
1,720,741
6
$26.9M 4.41%
438,477
7
$25.3M 4.13%
745,060
8
$21.2M 3.46%
+1,375,674
9
$20.8M 3.4%
1,729,378
10
$20.3M 3.32%
341,496
11
$20.2M 3.31%
503,398
+180,000
12
$18.6M 3.04%
789,698
13
$18.3M 3%
1,446,361
14
$17.8M 2.91%
5,075,970
-546,535
15
$16.5M 2.7%
549,262
16
$16.4M 2.68%
563,075
17
$15.9M 2.61%
98,924
18
$15M 2.46%
614,282
19
$14.7M 2.41%
315,722
20
$14.2M 2.33%
14,705,882
21
$13.5M 2.21%
700,000
+378,304
22
$13.1M 2.14%
1,303,399
23
$12.7M 2.08%
3,903,381
+300
24
$11.9M 1.95%
2,282,680
25
$11.9M 1.95%
395,700
1
2 3